Skip to content

Clinical trials

Phase 2/3 Neoplasm Metastasis trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2/3 Country / region: Netherlands Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20081
20122
20141
20171
20191
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status3
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Netherlands Cancer Institute2
Amsterdam UMC, location VUmc1
Associació per a la Recerca Oncologica, Spain1
Bellus Health Inc. - a GSK company1
Exelixis1
Novartis Pharmaceuticals1
Sanofi1
UMC Utrecht1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis9
Breast Neoplasms2
Colorectal Neoplasms2
Adenoma, Islet Cell1
Amyloidosis1
Arthritis, Rheumatoid1
Digestive System Neoplasms1
Familial Mediterranean Fever1
Gastrointestinal Diseases1
Hereditary Sensory and Autonomic Neuropathies1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.